Omeros Names Greg Perkins VP Of Regulatory Affairs |
|||
|
|||
Drug developer Omeros Corp. has named J. Greg Perkins as vice president of regulatory affairs. Perkins comes to Omeros from Solvay Pharmaceuticals Inc., where he served most recently as senior vice president for global scientific affairs and milestone review. Previously, he worked at Hoffman-LaRoche Inc. as vice president for drug regulatory affairs and Burroughs Wellcome Inc. as head of regulatory affairs for consumer products. Seattle-based Omeros has raised over $45 million in financing from: Brookstone Biotech Ventures, CSK Ventures, Encompass Ventures, Grosvenor Funds, Itochu Finance Corp., ITX International Equity Corp., Loewenthal Capital, Sagamore Bioventures, Southern Cross Capital, Suez Ventures, Summit Capital Partners, TransCosmos USA Inc., WRF Capital and 3V SourceOne Capital. http://www.omeros.com |
|||